OCTRI Pilot Project Awards 2017
Catalyst Pilot Awardees
In fiscal year 2017, OCTRI will fund two projects designed to enhance translational research at OHSU. These novel, collaborative, multidisciplinary studies will lead to further research and funding in translational research. The funding was made available through institutional support from the School of Medicine and the Office of the Vice President of Research.
Craig Dorrell
Assessment of anti-cancer drugs against patient-specific pancreatic cancer organoid cultures
Abstract
Peter Jacobs
iPancreas: Internet based on-demand artificial pancreas app-generator to accelerate clinical trials researchAbstract
Biomedical Innovation Program
The Biomedical Innovation Program (BIP) is designed to accelerate the movement of healthcare technologies from academia to the marketplace. In 2017, OCTRI will fund three collaborative, innovative pilot projects that address significant healthcare problems. The BIP is a collaboration between OCTRI and Technology Transfer & Business Development (TTBD), with additional funding and support from industry partners, Welch-Allyn, and GE Healthcare.
David Huang
Dry Eye Treatment DeviceAbstract
David Sheridan
Wearable Monitoring for Mental Health PatientsAbstract
David Simons
Glaucoma Tube Implant with Modulated FlowAbstract
Biomedical Innovation Program Drug Discovery
This track of BIP funding supports drug discovery platforms and early stage therapeutic technology projects, such as validation of drug targets, small molecules, vaccines, antibodies, and biologics. The BIP Drug Discovery program is a collaboration between OCTRI, Technology Transfer & Business Development (TTBD), and the OHSU Knight Cancer Institute.
Monika Davare
Development of a 'hit to lead' compound as a therapeutic agent to treat Ewing's sarcoma and subsets of hematological malignanciesAbstract
Beth Habecker & Michael Cohen
Novel compositions targeting protein tyrosine phosphatase sigma for nerve regeneration
Abstract